| Fatigue and cognitive impairment in Post-COVID-19 Syndrome: A systematic review and meta-analysis F Ceban, S Ling, LMW Lui, Y Lee, H Gill, KM Teopiz, NB Rodrigues, ... Brain, behavior, and immunity 101, 93-135, 2022 | 1343 | 2022 |
| Onset and frequency of depression in post-COVID-19 syndrome: A systematic review O Renaud-Charest, LMW Lui, S Eskander, F Ceban, R Ho, ... Journal of psychiatric research 144, 129-137, 2021 | 360 | 2021 |
| Real-world effectiveness of ketamine in treatment-resistant depression: A systematic review & meta-analysis Y Alnefeesi, D Chen-Li, E Krane, MY Jawad, NB Rodrigues, F Ceban, ... Journal of psychiatric research 151, 693-709, 2022 | 136 | 2022 |
| COVID-19 vaccination for the prevention and treatment of long COVID: A systematic review and meta-analysis F Ceban, D Kulzhabayeva, NB Rodrigues, JD Di Vincenzo, H Gill, ... Brain, behavior, and immunity 111, 211-229, 2023 | 80 | 2023 |
| Registered clinical trials investigating treatment of long COVID: a scoping review and recommendations for research F Ceban, A Leber, MY Jawad, M Yu, LMW Lui, M Subramaniapillai, ... Infectious Diseases 54 (7), 467-477, 2022 | 69 | 2022 |
| The abuse liability of ketamine: A scoping review of preclinical and clinical studies TT Le, IP Cordero, MY Jawad, J Swainson, JD Di Vincenzo, S Jaberi, ... Journal of psychiatric research 151, 476-496, 2022 | 59 | 2022 |
| Antisuicidal and antidepressant effects of ketamine and esketamine in patients with baseline suicidality: A systematic review AN Siegel, JD Di Vincenzo, E Brietzke, H Gill, NB Rodrigues, LMW Lui, ... Journal of psychiatric research 137, 426-436, 2021 | 58 | 2021 |
| The effectiveness, safety and tolerability of ketamine for depression in adolescents and older adults: a systematic review JD Di Vincenzo, A Siegel, O Lipsitz, R Ho, KM Teopiz, J Ng, LMW Lui, ... Journal of psychiatric research 137, 232-241, 2021 | 48 | 2021 |
| Brain-Derived Neurotrophic Factor (BDNF) as a biomarker of treatment response in patients with Treatment Resistant Depression (TRD): A systematic review & meta-analysis S Meshkat, Y Alnefeesi, MY Jawad, JD Di Vincenzo, NB Rodrigues, ... Psychiatry research 317, 114857, 2022 | 47 | 2022 |
| Active mechanisms of ketamine-assisted psychotherapy: A systematic review I Joneborg, Y Lee, JD Di Vincenzo, F Ceban, S Meshkat, LMW Lui, ... Journal of affective disorders 315, 105-112, 2022 | 42 | 2022 |
| Oral ketamine for depression: an updated systematic review S Meshkat, S Haikazian, JD Di Vincenzo, F Fancy, D Johnson, D Chen-Li, ... The World Journal of Biological Psychiatry 24 (7), 545-557, 2023 | 34 | 2023 |
| The effects of psychostimulants on cognitive functions in individuals with attention-deficit hyperactivity disorder: A systematic review A Mckenzie, S Meshkat, LMW Lui, R Ho, JD Di Vincenzo, F Ceban, B Cao, ... Journal of psychiatric research 149, 252-259, 2022 | 31 | 2022 |
| Glucagon-like peptide 1 (GLP-1) receptor agonists as a protective factor for incident depression in patients with diabetes mellitus: a systematic review DH Cooper, R Ramachandra, F Ceban, JD Di Vincenzo, TG Rhee, ... Journal of Psychiatric Research 164, 80-89, 2023 | 30 | 2023 |
| Real-world effectiveness of repeated ketamine infusions for treatment-resistant bipolar depression F Fancy, NB Rodrigues, JD Di Vincenzo, EH Chau, R Sethi, MI Husain, ... FOCUS 21 (4), 420-429, 2023 | 29 | 2023 |
| Pharmacogenomics of ketamine: a systematic review S Meshkat, NB Rodrigues, JD Di Vincenzo, F Ceban, S Jaberi, ... Journal of Psychiatric Research 145, 27-34, 2022 | 29 | 2022 |
| Safety, tolerability, and real-world effectiveness of intravenous ketamine in older adults with treatment-resistant depression: a case series O Lipsitz, JD Di Vincenzo, NB Rodrigues, DS Cha, Y Lee, D Greenberg, ... The American Journal of Geriatric Psychiatry 29 (9), 899-913, 2021 | 29 | 2021 |
| Vortioxetine for the treatment of post-COVID-19 condition: a randomized controlled trial RS McIntyre, L Phan, ATH Kwan, RB Mansur, JD Rosenblat, Z Guo, ... Brain 147 (3), 849-857, 2024 | 27 | 2024 |
| The therapeutic role of ketamine and esketamine in treating psychopathological domains of depression MY Jawad, JD Di Vincenzo, S Badulescu, KM Teopiz, A Tabassum, ... Neuropharmacology 223, 109299, 2023 | 25 | 2023 |
| The efficacy and safety of adjunctive intranasal esketamine treatment in major depressive disorder: a systematic review and meta-analysis MY Jawad, JD Di Vincenzo, F Ceban, S Jaberi, LMW Lui, ES Gillissie, ... Expert opinion on drug safety 21 (6), 841-852, 2022 | 25 | 2022 |
| The bidirectional association of nonalcoholic fatty liver disease with depression, bipolar disorder, and schizophrenia MY Jawad, S Meshkat, A Tabassum, A Mckenzie, JD Di Vincenzo, Z Guo, ... CNS spectrums 28 (5), 541-560, 2023 | 23 | 2023 |
